Related Experiment Video
Updated: Jul 9, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins
Zoltan Balazs1, Roberto A S Schweizer, Felix J Frey
1Institute of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland.
Dehydroepiandrosterone (DHEA) enhances 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity, shifting glucocorticoid conversion towards inactivation. This study reveals a mechanism for DHEA's antiglucocorticoid effects.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- 11beta-hydroxysteroid dehydrogenase (11beta-HSD) types 1 and 2 interconvert active and inactive glucocorticoids.
- Dysregulation of 11beta-HSD enzymes is linked to obesity, diabetes, hypertension, and cardiovascular disease.
- Dehydroepiandrosterone (DHEA) exhibits antiglucocorticoid effects, but the mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying DHEA's antiglucocorticoid effects.
- To investigate the impact of DHEA on 11beta-HSD type 1 and type 2 expression and activity.
- To identify key regulatory pathways involved in DHEA-mediated modulation of glucocorticoid metabolism.
Main Methods:
- Cell culture experiments using a rat cortical collecting duct cell line.
- In vivo studies involving C57BL/6J mice and Sprague-Dawley rats.
- Analysis of mRNA and protein expression, enzyme activity assays, and Western blotting.
Main Results:
- DHEA treatment significantly increased 11beta-HSD2 mRNA expression and activity in vitro and in vivo.
- DHEA administration led to a trend of reduced urinary corticosterone to 11-dehydrocorticosterone ratios in rats.
- DHEA modulated 11beta-HSD2 transcription via a phosphatidylinositol-3 kinase/Akt-dependent pathway, increasing C/EBP-beta expression.
Conclusions:
- DHEA induces a shift in enzyme expression favoring 11beta-HSD2 over 11beta-HSD1.
- This shift enhances the conversion of active to inactive glucocorticoids, explaining DHEA's antiglucocorticoid properties.
- CCAAT/enhancer-binding protein-alpha and -beta are identified as key regulators of HSD11B2 transcription, differentially controlling 11beta-HSD1 and 11beta-HSD2 expression.
Related Concept Videos
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Cushing Syndrome II: Pathophysiology
Hedgehog Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...

